期刊文献+

肝硬化患者血中组织因子途径抑制物及脂蛋白变化的研究 被引量:1

Study on TFPI and the level of serum lipoprotein in the patients with cirrhosis
暂未订购
导出
摘要 采用发色底物法等测定 5 3例肝硬化患者TFPI活性 (TFPI∶C)及血清脂蛋白水平。发现肝硬化患者TFPI∶C、高密度脂蛋白 (HDL -C)、低密度脂蛋白 (LDL -C)、极低密度脂蛋白 (VLDL -C)、脂蛋白 (α) [Lp(α) ]均低于正常对照组 (p均 <0 .0 1) ;肝功能损害程度越重 ,上述指标下降越明显 ;合并门静脉系血栓形成 (PT)组各项指标低于无合并PT组 ;肝硬化患者TFPI∶C水平与HDL -C、LDL -C、VLDL -C及Lp(α)水平呈正相关。提示肝硬化患者血清脂蛋白水平可能是TFPI活性降低的主要原因之一 。 To study the clinical significance of tissue factor pathway inhibitor(TFPI)and the serum lipoprotein in patients with cirrhosis,TFPI consistency(TFPI∶C)was determined with chromogenic peptide substrate method,and the serum lipoprotein were determined with an auto biochemical analyzer.In 53 pationts with cirrhosis,TFPI∶C?HDL-C?LDL-C?VLDL-C?Lp(α) were detected respectively,which are lower than those in the control (P<0.01).The more serious the liver function is,the worse the above targets are,especially in the cirrhosis pationts with trombosis of portal vein system(PT),of which the targets are lower than those without PT(P<0.01).TFPI∶C is positive correlated with the level of HDL-C?LDL-C?VLDL-C?Lp(α).The serum TFPI∶C and lipoprotein may be the makers in estimating the severity of the cirrhosis.The level of serum lipoprotein may be one of the causes to decrease the level of TFPI∶C,and the decrease of TFPI∶C may be related to the throbomsis of portal vein system in the pationts with cirrhosis.
出处 《临床肝胆病杂志》 CAS 北大核心 2001年第4期239-240,共2页 Journal of Clinical Hepatology
关键词 肝硬化 组织因子途径抑制物 脂蛋白 TFPI Cirrhosis tissue factor pathway inhibitor lipoprotein
  • 相关文献

参考文献6

二级参考文献25

  • 1Wun T C,J Biol Chem,1988年,263卷,6001页
  • 2顾天爵.生物化学(第三版)[M].北京:人民卫生出版社,1988..
  • 3王鸿利,血栓与止血检验技术,1992年,186页
  • 4Darrell H.G,Grawford,Shepherd R.W.et al.Boday composition in nonalcoholic cirrhosis:the effect of disease etiology and severity on nutritional compartments.Gastroenterology.1994,106:1611.
  • 5Merli M.Riggio O.Dally L.and PINC.Dose malnutrition affect survival in cirrhosis?Hepatology 1996,23:1041.
  • 6Dominic J.Nompleggi and Herbert L,Bonkovsky,Nutritional Supplementation in chronic liver disease:An analytical review. Hepatology 1994,19(2):518.
  • 7Maller M.J.Lautz H.U,Plogmann B,et al.Energy expenditure and substrate oxidation in patients with cirrhosis:the impact of cause,clinical staging and nutritional state.Hepatology.1992,15:782.
  • 8Gonzalez J.Periago J.L.Gil A.et al.Malnutrition-related polyunsaturated fatty acid changes in plasma lipid fractions of cirrhosis patients,metabolism 1992,41(9)954.
  • 9Cabre E.Nunez M.Gonzalez-Huix F.et al.Clinical and nutritional factors predicative of plasma lipid unsaturation,deficiency in advanced liver cirrhosis:A logistic regression analysis Am.J.Gastroenterology 1993,88(10):1738.
  • 10Cabre E,Periago J.L.Abad-laeruz A,et al.Plasma fatty acid profile in advanced cirrhosis:unsaturation deficit of lipid fractions Am.J, Gastroenterology 1990,85(2):1579.

共引文献35

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部